Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of twice-daily versus three-times-daily methylphenidate dosing in ADHD
TCTR20190915002Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Primary endpoints: ADHD symptom severity, Side effects and 1 more. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on TCTR20190915002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190915002.